This is a temporary backup site for TRENDS MENA while our primary website is being restored following a regional disruption affecting Amazon Web Services cloud infrastructure in the GCC.

Search Site

ADNOC Distribution 2025 dividend $700m

The company had reported EBITDA of $1.17 bn in 2025.

Empower okays $119.1m H2 2025 dividend

The dividend is equivalent to 43.75% of paid-up capital.

Alujain widens 2025 loss

The increase in loss is due to impairment charges, weaker prices.

Masar 2025 net profit $262m

Higher land plot sales boost revenue and operating income.

Tasnee’s 2025 losses deepen

The petrochemicals' company's revenue also fell 17.7 percent.

Credit Suisse fails NYSE listing criteria

  • Credit Suisse is listed in New York under a "Depositary Shares" scheme that allows foreign firms to sell stock in the United States.
  • Its share price crumbled under the pressure of fears of contagion from the collapse of three US regional banks.

Zurich, Switzerland – Battered shares in crisis-hit Credit Suisse no longer meet criteria for listing on the New York Stock Exchange, the bank said Wednesday, adding that its upcoming sale to UBS would resolve the issue.

“The New York Stock Exchange notified Credit Suisse on May 1… that it is no longer in compliance with the NYSE’s continued listing minimum price criteria,” Credit Suisse said in a statement.

Credit Suisse is listed in New York under a “Depositary Shares” scheme that allows foreign firms to sell stock in the United States.

Under NYSE rules, shares must trade for at least $1.00 for 30 consecutive days to qualify for listing.

But the financial firm, whose share price crumbled under the pressure of fears of contagion from the collapse of three US regional banks, is slated to be taken over by historic rival UBS in a rescue organized by Bern.

Since the deal, the share price has hovered around 0.76 Swiss francs ($0.83) — in line with the three-billion-franc valuation for the acquisition and down around 94 percent compared with March 2021, before Credit Suisse was hit by a string of shocks and scandals.

“Credit Suisse expects that the deficiency will be cured upon completion of the acquisition by UBS,” which will mean its own shares are exchanged for UBS stock and delisted in New York, the statement said.